Simplex Trading
CRDF icon

Simplex Trading’s Cardiff Oncology CRDF Stock Holding History

Simplex Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260 Sell
200
-11,200
-98% -$17.8K ﹤0.01% 9031
2026
Q1 		$18.5K Buy
11,400
+10,900
+2,180% +$22.4K ﹤0.01% 6842
2025
Q4 		$1.41K Sell
500
-64,100
-99% -$149K ﹤0.01% 7941
2025
Q3 		$133K Sell
64,600
-7,300
-10% -$20.2K ﹤0.01% 5424
2025
Q2 		$226K Buy
71,900
+46,600
+184% +$142K ﹤0.01% 4382
2025
Q1 		$79K Sell
25,300
-16,400
-39% -$64.9K ﹤0.01% 5309
2024
Q4 		$180K Buy
41,700
+11,100
+36% +$34.7K ﹤0.01% 4616
2024
Q3 		$81K Buy
30,600
+13,500
+79% +$31.9K ﹤0.01% 5429
2024
Q2 		$37K Buy
17,100
+5,900
+53% +$22.2K ﹤0.01% 6357
2024
Q1 		$59K Buy
+11,200
New +$29.8K ﹤0.01% 6107
2023
Q2 		– Sell
-2,800
Closed -$4K – 9103
2023
Q1 		$4K Sell
2,800
-2,000
-42% -$3.43K ﹤0.01% 8151
2022
Q4 		$6K Sell
4,800
-22,600
-82% -$32.4K ﹤0.01% 7916
2022
Q3 		$42K Sell
27,400
-27,000
-50% -$65K ﹤0.01% 6669
2022
Q2 		$119K Buy
54,400
+33,200
+157% +$55.6K ﹤0.01% 5326
2022
Q1 		$52K Buy
21,200
+13,600
+179% +$48.1K ﹤0.01% 7062
2021
Q4 		$45K Buy
7,600
+600
+9% +$3.58K ﹤0.01% 7390
2021
Q3 		$46K Hold
7,000
– – ﹤0.01% 7591
2021
Q2 		$46K Buy
7,000
+6,584
+1,583% +$55.8K ﹤0.01% 7735
2021
Q1 		$385K Buy
416
+388
+1,386% +$4.71K ﹤0.01% 3765
2020
Q4 		$50K Sell
28
-184
-87% -$3.23K ﹤0.01% 6175
2020
Q3 		$300K Buy
+212
New +$1.4K ﹤0.01% 3598

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simplex Trading's CRDF Position: Q2 2026 in Review

Simplex Trading reduced its Cardiff Oncology (CRDF) stake by 81% in Q2 2026, selling an estimated $21.3K and leaving 3,060 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #8301.

Simplex Trading first reported a position in CRDF in Q4 2015 and has held it in 26 quarters since. The position peaked at $387K in Q1 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Simplex Trading held 3,060 shares of Cardiff Oncology worth $3.98K as of Q2 2026.
  • Simplex Trading sold 13,394 Cardiff Oncology shares in Q2 2026, an estimated $21.3K.
  • Cardiff Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8301 holding.
  • Simplex Trading first reported a position in Cardiff Oncology in Q4 2015 and has held it in 26 quarters since.
  • Simplex Trading's Cardiff Oncology position peaked at $387K in Q1 2025.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.